![Tae Park Sang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tae Park Sang
Direktor/Vorstandsmitglied bei Oxford Cancer Biomarkers Ltd.
Ursprung des Netzwerks ersten Grades von Tae Park Sang
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Oxford Cancer Biomarkers Ltd.
![]() Oxford Cancer Biomarkers Ltd. Hospital/Nursing ManagementHealth Services Oxford Cancer Biomarkers Ltd. provides cancer treatment services. It offers a suite of drug-specific companion diagnostic kits that allow the biomarker to be directly measured in tumor biopsies or patient DNA and thereby patients that respond favorably to the drug identified. The company was founded by David Kerr and Nick LaThangue in 2012 and is headquartered in Oxford, the United Kingdom.
6
| Holding Company | Hospital/Nursing Management | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Tae Park Sang
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
CARA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal | |
Oxford Brookes University | College/University | Undergraduate Degree | |
Oxis Energy Ltd.
![]() Oxis Energy Ltd. Electrical ProductsProducer Manufacturing Oxis Energy Ltd. manufactures sulphur polymer rechargeable batteries. It develops technology around sulfur based cathode materials, highly stable electrolyte systems and anode made of lithium metal and intercalation materials. The firm offers stable cathode and electrolyte systems which are optimized for performance with different anodes including lithium-metal. Its products include: cell components, standard pouch cell, customized cell and batteries. The company was founded by Ken Pelton, Justin Gaisford Martin, Andrea Giacomo Mica and Gleb Ivanov in 2004 and is headquartered in Abingdon, the United Kingdom. | Electrical Products | Director/Board Member | |
Tillotts Pharma AG
![]() Tillotts Pharma AG Pharmaceuticals: MajorHealth Technology Tillotts Pharma AG manufactures pharmaceuticals for treatment of gastrointestinal diseases. The firm specializes in the therapy of the lower gastrointestinal tract. It offers Asacol, Entocort, Colpermin, Tillhepo and VistaPrep. The company was founded in 1986 and is headquartered in Ziefen, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Scancell Ltd.
![]() Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Ecole Nationale des Ponts et Chaussées | College/University | Masters Business Admin | |
Queensland University of Technology | College/University | Graduate Degree | |
University of Lund | College/University | Graduate Degree | |
Commerce Decisions Ltd.
![]() Commerce Decisions Ltd. Packaged SoftwareTechnology Services Commerce Decisions Ltd. develops enterprise software. It offers software and services to support the procurement and post contract review processes for both buyers and suppliers. The company was founded by Steven Dey and John Thompson and is headquartered in Oxfordshire, the United Kingdom. | Packaged Software | Director/Board Member | |
Oxford Technology Management Ltd.
![]() Oxford Technology Management Ltd. Investment ManagersFinance Oxford Technology Management Ltd. (Oxford Technology) a venture capital firm founded by Mr. Lucius Cary in 1972. The firm is headquartered in Oxford, UK. | Investment Managers | Private Equity Investor | |
Haemostatix Ltd.
![]() Haemostatix Ltd. Pharmaceuticals: MajorHealth Technology Haemostatix Ltd. designs and develops solutions for haemostasis and thrombosis. Its products include Rapid and effective haemostatic action which is new class of topical coagulant or haemostat that is applied directly to a wound during surgery to control bleeding, and ready-to-use formulations, blood-free ingredients and a new class with a unique mode of action. The company was founded by Sarah Middleton and Alison Goodall in 2003 and is headquartered in Nottingham, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Esperante Ltd.
![]() Esperante Ltd. Investment ManagersFinance Esperante Ltd. operates as a venture investment company controlled by C&P Group Holdings. The company was founded on April 29, 1986 and is headquartered in Maidenhead, the United Kingdom. | Investment Managers | Chief Executive Officer | |
Esperante BV
![]() Esperante BV Investment ManagersFinance Esperante BV (Esperante) is a Dutch based venture capital firm which was founded by Dean Slagel in 2004. Esperante is a seed investor which invests in emerging biotechnology companies engaged in the development of novel therapeutics in areas of major unmet medical need. The firm has a portfolio of investments across France, the UK and the US. The firm provides investee companies with extended management resources, particularly in business development, as a complement to their financial contribution. They also conduct scientific and intellectual property evaluations using confidential life science industry consultants. | Investment Managers | Chief Executive Officer | |
LU Holding AB
![]() LU Holding AB Investment ManagersFinance LU Holding AB (LU Holding) is a venture capital subsidiary of University of Lund founded in 1994. The firm is headquartered in Lund, Sweden. | Investment Managers | Private Equity Investor | |
ImmunoBiology Ltd.
![]() ImmunoBiology Ltd. BiotechnologyHealth Technology ImmunoBiology Ltd. develops next generation of vaccines for infectious diseases. It develops vaccines that protect against pathogens by mimicking the natural immune response to infection. The firm offers ImmBioVax and ImmunoBodies vaccines. The company was founded by Camilo Colaco in 1999 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Canbex Therapeutics Ltd.
![]() Canbex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Canbex Therapeutics Ltd. engages in the development of novel peripherally-acting cannabinoid agonists and mimetics for the treatment of multiple sclerosis spasticity and pain. Its lead drug candidate, VSN 16, has been established as a potent, stable and orally-available agonist of GPR-55 with a clear anti-spasticity effect in a validated preclinical model. The company was founded by David Baker, Gavin Giovannoni, Cristina Visintin, Gareth Pryce and David Lawrence Selwood in 2005 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
BPC INSTRUMENTS AB | Electronic Equipment/Instruments | Director/Board Member | |
SCANCELL HOLDINGS PLC | Biotechnology | Director/Board Member | |
Microvisk Ltd.
![]() Microvisk Ltd. Electronic Equipment/InstrumentsElectronic Technology Microvisk Ltd. engages in the manufacture and development of micro-viscometer based on micro electro mechanical sensors technology for medical field. The firm's products include CoagMax, CoagLite, CoagManager and SmartStrip. It develops technology for the detection and analysis of a fluid's properties using a cantilever-based micro-viscometer. The company was founded by Vladislav Djakov, Paul Morgan Vernon and Jeremy Burford Peckham in 2004 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Arquer Diagnostics Ltd.
![]() Arquer Diagnostics Ltd. Medical/Nursing ServicesHealth Services Arquer Diagnostics Ltd. develops proprietary diagnostic immunoassays for the detection of prostate and bladder cancer using urine samples. Its develops non-invasive, urine-based ELISA and Point-of Care tests meet the increased demand for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes. The firm will commercialise ELISA and point-of-care urine tests for prostate and bladder cancer for use in the urology clinic, hospital lab and the GP’s surgery. The company was founded by David Nicholas Miller-Jones and William Dawson in 2007 and is headquartered in Sunderland, the United Kingdom. | Medical/Nursing Services | Director/Board Member | |
Esperante AB | Chief Executive Officer | ||
OrganOx Ltd.
![]() OrganOx Ltd. Electronic Equipment/InstrumentsElectronic Technology OrganOx Ltd. develops a medical device for liver transplantation. The firm's product OrganOx metra, is a fully automated normothermic liver perfusion device for improved organ preservation. It also engages in research and development of transplantation related technologies. The company was founded by Peter Friend and Constantin Coussios in April 2008 and is headquartered in Oxford, the United Kingdom. | Electronic Equipment/Instruments | Director/Board Member | |
Celleron Therapeutics Ltd.
![]() Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Celleron Therapeutics Ltd. is an oncology company based in Oxford, UK. Celleron has deep relationships with Oxford University and is located on the Oxford Science Park. The British company focuses on the clinical development of new and innovative therapies to treat cancer. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The company's lead products are currently in clinical trials, and they have a biomarker platform that allows them to identify responsive patients. Celleron Therapeutics Ltd. was founded in 2004, and the CEO is Nick la Thangue. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Longwall Venture Partners LLP
![]() Longwall Venture Partners LLP Investment ManagersFinance Longwall Venture Partners LLP (Longwall Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Oxford, the United Kingdom. | Investment Managers | Founder | |
Ferring Pharmaceuticals Ltd.
![]() Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
OxOnc Development LP
![]() OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Corporate Officer/Principal | |
Oxford Vacmedix UK Ltd.
![]() Oxford Vacmedix UK Ltd. Pharmaceuticals: MajorHealth Technology Oxford Vacmedix UK Ltd. develops vaccines for the prevention of infectious diseases and cancer. The company was founded by Patrick Charles Morrish Baddeley in 2012 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
OxSonics Ltd.
![]() OxSonics Ltd. Hospital/Nursing ManagementHealth Services OxSonics Ltd. provides treatments to solid tumour cancer patients. Its drug delivery platform, SonoTran, delivers drugs throughout tumour volumes including to those areas that lie farthest from blood vessels. The company also provides on-screen feedback as to where and when drug delivery has taken place, maximizing the potential of complete tumour coverage. OxSonics was founded by Colin Story, Constantin Coussios, Robert Carlisle and Christian Coviello in July 2013 and is headquartered in Oxford, the United Kingdom. | Hospital/Nursing Management | Director/Board Member | |
Cognibotics AB
![]() Cognibotics AB Industrial MachineryProducer Manufacturing Cognibotics AB specializes in methods and services for the determination of robot properties. It offers solutions for determining joint properties for enabling robots to work in various application areas where existing calibration techniques and current robot solutions are not tractable. The compnay was founded by Klas Ingemar Nilsson and Olof Sornmo in 2013 and is headquartered in Lund, Sweden. | Industrial Machinery | Chairman | |
Caristo Diagnostics Ltd.
![]() Caristo Diagnostics Ltd. Medical SpecialtiesHealth Technology Caristo Diagnostics Ltd. engages in the development of cardiovascular diagnostic tools. The company was founded by Charalambos Antoniades on June 22, 2018 and is headquartered in Oxford, the United Kingdom. | Medical Specialties | Director/Board Member | |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Biotechnology | Chief Executive Officer | |
Ingenox Therapeutics Ltd.
![]() Ingenox Therapeutics Ltd. Hospital/Nursing ManagementHealth Services Ingenox Therapeutics Ltd. provides cancer treatment services. The private company is based in Oxford, UK. The CEO of the British company is Nick la Thangue. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Altacor Ltd.
![]() Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Fieldly AB
![]() Fieldly AB Packaged SoftwareTechnology Services Fieldly AB develops project management systems. It provides construction companies with a simple and easy to use web based management system for the Office combined with a fully integrated mobile app for the Field. The firm’s applications include managing all client information, project quotations, preparation and approval workflows, work order assignment, scheduling and planning, jobsite location and contact details, field reporting, job progress tracking, with real-time time and expense reporting. The company was founded in 2013 by Daniel Nils Krusenstråhle and Sven Karl Georg Paulin Hansson and is headquartered in Malmo, Sweden. | Packaged Software | Director/Board Member |
Statistik
International
Vereinigtes Königreich | 32 |
Schweden | 7 |
Frankreich | 5 |
Vereinigte Staaten | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 21 |
Finance | 8 |
Consumer Services | 6 |
Electronic Technology | 5 |
Commercial Services | 4 |
Operativ
Director/Board Member | 40 |
Chief Executive Officer | 8 |
Corporate Officer/Principal | 5 |
Private Equity Investor | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Matthew Frohn | 20 |
Dean Marc Slagel | 18 |
Erik Anders Boman | 8 |
David Kerr | 5 |
Nick la Thangue | 4 |
Mee Lee Kyoung | 1 |
- Börse
- Insiders
- Tae Park Sang
- Unternehmensverbindungen